IP Library Granted Patent US 11,464,717
Granted Patent B2
US 11,464,717 · App. 16/470,411 · Granted Oct 11, 2022

Oral care composition containing at least one biosurfactant and fluoride

Inventors: Hans Henning Wenk (Mülheim an der Ruhr, DE); Kathrin Daniela Brandt (Düsseldorf, DE); Martin Schilling (Bonn, DE); Verena Dahl (Bergisch Gladbach, DE); Jochen Kleinen (Heinsberg, DE); Joachim Venzmer (Essen, DE)
Assignee: Evonik Operations GmbH
A61K8/21A61K8/602A61K8/731A61Q11/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,717
App. No.
16/470,411
Granted
Oct 11, 2022
Kind
B2
Abstract

The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.

Claims (44)

1. An oral care composition comprising from 0.005 wt. % to 20 wt. % of a biosurfactant and a fluoride ion source based on the total weight of the composition, wherein the fluoride ion source is contained in an amount sufficient to supply from 500 to 1500 ppm fluoride ion, based on the total weight of the composition, wherein the biosurfactant is a rhamnolipid and is contained in an amount from 0.1 wt. % to 2 wt. %, based on the total weight of the composition,

wherein the rhamnolipid is a compound of formula (1)

wherein

m is 1,

n is 0 or 1

R 1 and R 2 are an organic radical having from 5 to 13 carbon atoms,

wherein the rhamnolipid comprises from 51% by weight to 75% by weight of diRL-C10C10 and from 0.5% by weight to 2% by weight of monoRL-C10C10,

wherein the weight ratio of the di-rhamnolipids and monorhamnolipids is greater than 90:10, and

wherein the percentages by weight refer to the sum total of all rhamnolipids present.

2. The oral care composition according to claim 1 ,

wherein the rhamnolipids comprise from 0.1% by weight to 25% by weight of diRL-C8C10, wherein the percentages by weight refer to the sum total of all biosurfactant present.

3. The oral care composition according to claim 1 , wherein the fluoride ion source is selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, potassium monofluorophosphate, sodium monofluorophosphate, ammonium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluorides such as olaflur N′-octadecyltrimethylendiamine-N,N,N′-tris (2-ethanol)-dihydrofluoride and ammonium fluoride.

4. The oral care composition according to claim 1 , wherein the fluoride ion source is contained in an amount sufficient to supply from 100 to 1000 ppm fluoride ion, based on the total weight of the composition.

5. The oral care composition according to claim 1 , rhamnolipid comprises-from 2% by weight to 10% by weight of diRL-C8C10

wherein the weight ratio of the di-rhamnolipids and monorhamnolipids is greater than 98:2.

6. The oral care composition according to claim 1 , comprising from 0.1 wt. % to 2 wt. % of the biosurfactant, wherein the composition reduces formation of insoluble complexes of fluoride,

wherein the rhamnolipid comprises from 51% by weight to 95% by weight of diRL-C10C10,

from 0.5% by weight to 3% by weight of monoRL-C10C10, and

from 0.5% by weight to 15% by weight of diRL-C10C12:1, wherein the percentages by weight refer to the sum total of all rhamnolipids present, and

wherein the weight ratio of the di-rhamnolipids and monorhamnolipids is greater than 98:2.

7. The oral care composition according to claim 1 , wherein the composition reduces staining of teeth, and wherein the rhamnolipid comprises from 51% by weight to 95% by weight of diRL-C10C10,

from 0.5% by weight to 3% by weight of monoRL-C10C10,

from 0.5% by weight to 15% by weight of diRL-C10C12:1, and

from 0.1% by weight to 25% by weight of diRL-C8C10, where the percentages by weight refer to the sum total of all rhamnolipids present, and

wherein the weight ratio of the di-rhamnolipids and monorhamnolipids is greater than 98:2.

8. The oral care composition according to claim 1 , wherein the composition improves deposition/retention of fluoride on teeth, wherein the rhamnolipid comprises

from 51% by weight to 95% by weight of diRL-C10C10,

from 0.5% by weight to 3% by weight of monoRL-C10C10,

from 3% by weight to 12% by weight of diRL-C10C12:1, and

from 2% by weight to 10% by weight of diRL-C8C10,

where the percentages by weight refer to the sum total of all rhamnolipids present, and

wherein the weight ratio of the di-rhamnolipids and monorhamnolipids is greater than 97:3.

9. The oral care composition according to claim 2 , wherein the fluoride ion source is selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, potassium monofluorophosphate, sodium monofluorophosphate, ammonium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluorides such as olaflur N′-octadecyltrimethylendiamine-N,N,N′-tris (2-ethanol)-dihydrofluoride and ammonium fluoride.

10. The oral care composition according to claim 2 , wherein the fluoride ion source is contained in an amount sufficient to supply from 200 to 500 ppm fluoride ion, based on the total weight of the composition.

11. The oral care composition according to claim 2 , wherein the biosurfactant is contained in an amount from 0.1 wt. % to 50 wt. %, based on the total weight of the composition.

12. The oral care composition according to claim 3 , wherein the fluoride ion source is contained in an amount sufficient to supply from 200 to 500 ppm fluoride ion, based on the total weight of the composition.

13. The oral care composition according to claim 3 , wherein the biosurfactant is contained in an amount from 0.1 wt. % to 50 wt. %, based on the total weight of the composition.

14. The oral care composition according to claim 4 , wherein the biosurfactant is contained in an amount from 0.1 wt. % to 50 wt. %, based on the total weight of the composition.

15. The oral care composition according to claim 2 , comprising from 0.1 wt. % to 2 wt. % of the rhamnolipid and wherein the fluoride ion source is contained in an amount sufficient to supply from 500 to 1500 ppm fluoride ion.

16. The oral care composition according to claim 5 , wherein the biosurfactant wherein the composition reduces formation of insoluble complexes of fluoride.

17. The oral care composition according to claim 5 , wherein the composition wherein the composition reduces staining of teeth.

18. The oral care composition according to claim 5 , wherein the composition wherein the composition improves deposition/retention of fluoride on teeth.

19. The oral care composition according to claim 1 , wherein R 1 and R 2 are selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH 2 ) o where o is from 1 to 23.

20. The oral care composition according to claim 5 , wherein R 1 and R 2 are selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl and tridecenyl and (CH 2 ) o where o is from 4 to 12.

Assignments (2)
CHANGE OF NAME Recorded Dec 27, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051428/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2019
From: WENK, HANS HENNING; BRANDT, KATHRIN DANIELA; SCHILLING, MARTIN; DAHL, VERENA; KLEINEN, JOCHEN; VENZMER, JOACHIM
To: EVONIK DEGUSSA GMBH
Reel/Frame 049510/0469 →
Priority Claims (1)
EP 17155558 · Feb 10, 2017 · regional
Continuity (1)
Related Publication 20190307657A1 · Oct 10, 2019
Cited By (2)
US 12,448,588 US 12,497,426